Citations to this article

FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.
K Migita, … , A Mizokami, S Nagataki
K Migita, … , A Mizokami, S Nagataki
Published August 1, 1995
Citation Information: J Clin Invest. 1995;96(2):727-732. https://doi.org/10.1172/JCI118116.
View: Text | PDF
Research Article Article has an altmetric score of 3

FK506 augments activation-induced programmed cell death of T lymphocytes in vivo.

Abstract

FK506 is an immunosuppressive drug that inhibits T cell receptor-mediated signal transduction. This drug can induce immunological tolerance in allograft recipients. In this study, we investigated the in vivo effects of FK506 on T cell receptor-mediated apoptosis induction. Injection of anti-CD3 antibody (Ab) in mice resulted in the elimination of CD4+ CD8+ thymocytes by DNA fragmentation. FK506 treatment significantly augmented thymic apoptosis induced by in vivo anti-CD3 Ab administration. Increased thymic apoptosis resulted in the disappearance of CD4+ CD8+ thymocytes after anti-CD3 Ab/FK506 treatment. DNA fragmentation triggered by FK506 was induced exclusively in antigen-stimulated T cells, since enhanced DNA fragmentation induced by in vivo staphylococcal enterotoxin B (SEB) injection was confirmed in SEB-reactive V beta 8+ thymocytes but not in SEB-nonreactive V beta 6+ thymocytes. In addition to thymocytes, mature peripheral T cells also die by activation-induced programmed cell death. A similar effect of FK506 on activation-induced programmed cell death was observed in SEB-activated peripheral spleen T cells. In contrast, cyclosporin A treatment did not enhance activation-induced programmed cell death of thymocytes and peripheral T cells. Apoptosis is required for the generation and maintenance of self-tolerance in the immune system. Our findings suggest that FK506-triggered apoptosis after elimination of antigen-activated T cells may represent a potential mechanism of the immunological tolerance achieved by FK506 treatment.

Authors

K Migita, K Eguchi, Y Kawabe, T Tsukada, A Mizokami, S Nagataki

×

Total citations by year

Year: 2019 2014 2013 2012 2011 2009 2008 2006 2005 2003 2002 2001 2000 1999 1998 1997 1996 Total
Citations: 1 1 1 1 1 1 1 2 2 2 4 5 4 4 6 1 1 38
Citation information

Citations to this article (38)

Title and authors Publication Year
Calcineurin regulates cyclin D1 stability through dephosphorylation at T286
T Goshima, M Habara, K Maeda, S Hanaki, Y Kato, M Shimada 		Scientific Reports 2019
Experimental evidence that mutated-self peptides derived from mitochondrial DNA somatic mutations have the potential to trigger autoimmunity
L Chen, B Duvvuri, J Grigull, R Jamnik, JE Wither, GE Wu 		Human Immunology 2014
Dendritic cells loaded with FK506 kill T cells in an antigen-specific manner and prevent autoimmunity in vivo
DE Orange, NE Blachere, J Fak, S Parveen, MO Frank, M Herre, S Tian, S Monette, RB Darnell 		eLife 2013
Treg Cell Resistance to Apoptosis in DNA Vaccination for Experimental Autoimmune Encephalomyelitis Treatment
Y Kang, Y Sun, J Zhang, W Gao, J Kang, Y Wang, B Wang, G Xia, P Villoslada 		PloS one 2012
Successful Treatment of HTLV-1-Related Overlap Syndrome Using Tacrolimus
Y Izumi, H Kojima, Y Koga, K Yokota, H Mori, T Ohno, T Miyashita, M Ito, M Motomura, M Mine, H Ezaki, Y Jiuchi, D Niino, K Ohshima, K Migita 		Internal Medicine 2011
Kelley's Textbook of Rheumatology
J Degroot, AM Zuurmond, PP Tak 		Kelley's Textbook of Rheumatology 2009
Studies in Natural Products Chemistry
M Seki 		Studies in Natural Products Chemistry 2008
The Influence of Immunosuppressive Drugs on T- and B-cell Apoptosis via p53-Mediated Pathway In Vitro and In Vivo
A Boldt, MJ Barten, A Sagner, FW Mohr, V Adams, S Dhein, JF Gummert 		Transplantation 2006
Successful treatment using tacrolimus (FK506) in a patient with TNF receptor-associated periodic syndrome (TRAPS) complicated by monocytic fasciitis
H Ida, T Aramaki, K Arima, T Origuchi, A Kawakami, K Eguchi 		Rheumatology (Oxford, England) 2006
Overview of tacrolimus-based immunosuppression after heart or lung transplantation
H Reichenspurner 		The Journal of Heart and Lung Transplantation 2005
Effect of FK506 on the interleukin 15-driven proliferation and apoptosis of anti-CD3-activated umbilical cord blood T cells
SJ Lin, DC Yan, ML Kuo, PJ Cheng, SS Hsiao, TL Tsai 		Annals of Allergy Asthma & Immunology 2005
Tacrolimus: A Further Update of its Use in the Management of Organ Transplantation
LJ Scott, K McKeage, SJ Keam, GL Plosker 		Drugs 2003
The role of mitochondria in nitric oxide-mediated thymocyte apoptosis
K Migita, F Tanaka, S Abiru, H Ida, Y Izumi, A Kawakami, K Eguchi 		Immunology Letters 2003
The T-cell apoptosis in the early period after renal allograft transplantation
P Wierzbicki, G Korczak-Kowalska, M Durlik, D Kłosowska, J Wyzgał, L Pączek, M Lao, A Górski 		Transplantation Proceedings 2002
Differential Modulation of Apoptosis and Necrosis by Antioxidants in Immunosuppressed Human Lymphocytes
M Rojas, MT Rugeles, DP Gil, P Patiño 		Toxicology and Applied Pharmacology 2002
Combination of tacrolimus, methotrexate, and methylprednisolone prevents acute but not chronic graft-versus-host disease in unrelated bone marrow transplantation:
H Ogawa, T Soma, N Hosen, T Tatekawa, A Tsuboi, Y Oji, H Tamaki, M Kawakami, K Ikegame, M Murakami, T Fujioka, EH Kim, Y Oka, H Sugiyama 		Transplantation 2002
Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production1:
H Jiang, C Wynn, F Pan, A Ebbs, LM Erickson, M Kobayashi 		Transplantation 2002
Correlation Between Decreased Apoptosis and Multidrug Resistance (MDR) in Murine Leukemic T Cell Lines
EC Lopes, MG García, L Vellón, E Alvarez, SE Hajos 		Leukemia & Lymphoma 2001
Novel immunosuppressive effect of FK506 by augmentation of T cell apoptosis
Y Hashimoto, N Matsuoka, A Kawakami, M Tsuboi, T Nakashima, K Eguchi, T Tomioka, T Kanematsu 		Clinical & Experimental Immunology 2001
APOPTOSIS AND REJECTION IN RAT INTESTINAL TRANSPLANTATION: CORRELATION WITH FK 506 DOSES AND DONOR SPECIFIC BONE MARROW INFUSIONS:
G Vennarecci, M Berho, A Sommariva, AB Neto, EP Misiakos, L Inverardi, P Ruiz, C Ricordi, AG Tzakis 		Transplantation 2001
Modern Immunosuppressives
HJ Schuurman, G Feutren, JF Bach 		2001
Immunomodulatory effects of extracorporeal photochemotherapy in patients with extensive chronic graft-versus-host disease
T Alcindor, G Gorgun, KB Miller, TF Roberts, K Sprague, DP Schenkein, FM Foss 		Blood 2001
Induction of apoptosis of activated murine splenic T cells by cycloprodigiosin hydrochloride, a novel immunosuppressant
T Azuma, N Watanabe, H Yagisawa, H Hirata, M Iwamura, Y Kobayashi 		Immunopharmacology 2000
Apoptosis in rheumatic diseases
T Grodzicky, KB Elkon 		The American Journal of Medicine 2000
Induction of apoptosis in mouse brain capillary endothelial cells by cyclosporin a and tacrolimus
S Kochi, H Takanaga, H Matsuo, H Ohtani, M Naito, T Tsuruo, Y Sawada 		Life Sciences 2000
A 12-DAY COURSE OF FK506 ALLOWS LONG-TERM ACCEPTANCE OF SEMI-IDENTICAL LIVER ALLOGRAFT IN INBRED MINIATURE SWINE1:
F Oike, S Talpe, M Otsuka, JP Dehoux, J Lerut, JB Otte, P Gianello 		Transplantation 2000
Dialysis and transplantation
LC Paul 		Current Opinion in Nephrology and Hypertension 1999
Prevention of antigen-induced bronchial hyperreactivity and airway inflammation in sensitized guinea-pigs by tacrolimus
JR Silva, C Ruffié, J Lefort, MA Nahori, BB Vargaftig, M Pretolani 		Mediators of Inflammation 1999
Tolerance after liver transplantation: does it exist and can immunosuppression be withdrawn?
SM Riordan, R Williams 		Journal of Hepatology 1999
FK506 MARKEDLY ENHANCES APOPTOSIS OF ANTIGEN-STIMULATED PERIPHERAL T CELLS BY DOWN-REGULATION OF Bcl-xL1:
K Migita, T Origuchi, Y Kawabe, M Tominaga, H Ida, A Kawakami, K Eguchi 		Transplantation 1999
APOPTOSIS, GRAFT REJECTION, AND TRANSPLANTATION TOLERANCE
D Kabelitz 		Transplantation 1998
Tacrolimus-induced apoptosis and its prevention by interleukins in mitogen-activated human peripheral-blood mononuclear cells
A Horigome, T Hirano, K Oka 		Immunopharmacology 1998
Immunopharmacological studies on experimental allergic encephalomyelitis in DA rats
H Nagai, M Goto, H Kamada, K Boda, K Kitagaki, Y Takaoka 		General Pharmacology: The Vascular System 1998
Long-Term Comparison of Tacrolimus Versus Cyclosporine in Liver Transplantation
RH Wiesner 		Transplantation Proceedings 1998
Antigen-Induced Death of T-Lymphocytes
D Kabelitz, O Janssen 		Pediatric Pathology & Molecular Medicine 1998
A LONG-TERM COMPARISON OF TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN LIVER TRANSPLANTATION1: A Report of the United States FK506 Study Group2
RH Wiesner 		Transplantation 1998
Tacrolimus: An Update of its Pharmacology and Clinical Efficacy in the Management of Organ Transplantation
CM Spencer, KL Goa, JC Gillis 		Drugs 1997
DEPLETION OF THE MATURE CD4+8- THYMOCYTE SUBSET BY FK506 ANALOGS CORRELATES WITH THEIR IMMUNOSUPPRESSIVE AND CALCINEURIN INHIBITORY ACTIVITIES
S Koprak, A Sirotina, H Ok, FJ Dumont 		Transplantation 1996

Advertisement